Organocatalytic asymmetric dearomatization
of 3-nitroindoles and 3-nitrobenzothiophenes by reaction with ethyl
4-mercapto-2-butenoate has been developed. A range of chiral tetrahydrothiopheneindolines
and tetrahydrothiophenebenzothiophenes bearing three contiguous
stereocenters are obtained in high yields with good diastereoselectivities
and excellent enantioselectivities. This is the first example of thiol-triggered
catalytic asymmetric dearomatization of 3-nitroindoles and 3-nitrobenzothiophenes.
A highly diastereo- and enantioselective
cyclopropanation reaction
of 3-acylcoumarins with 3-halooxindoles catalyzed by an organocatalyst
through a [2 + 1] Michael/intramolecular cyclization process was developed.
This scenario provides a facile strategy to access spirooxindole-cyclopropa[c]coumarin compounds bearing three continuous stereocenters,
including two vicinal quaternary all-carbon stereocenters with high
to excellent diastereo- and enantioselectivities. The HRMS study revealed
the vital importance of the ammonium ylide intermediate in the catalytic
process.
Xylastriasan A (1), a new cytochalasan alkaloid with a rare 5/6/6/5/6 pentacyclic skeleton, and ergosterol (2) were isolated from the ethanol extract of fruiting bodies of the fungus Xylaria striata. Their structures were determined by analysis of their spectroscopic data. Compound 1 exhibited weak cytotoxic activity against HEPG2, B16 and A549 cell lines with IC values of 93.61, 85.61 and 91.58 μM, respectively. Ergosterol (2) potentiated pentobarbital-induced sleep by not only increasing the number of falling asleep and prolonging sleeping time but also reducing sleep latency at a dosage of 5 mg/kg.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.